High tumor mutation burden predicts favorable outcome among patients with aggressive histological subtypes of lung adenocarcinoma: A population-based single-institution study.

CONCLUSION: TMB was an independent biomarker of favorable prognosis in our cohort of lung adenocarcinoma despite being associated with predominant histological subtypes considered aggressive. PMID: 32585428 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32585428?dopt=Abstract

Source: Neoplasia - June 21, 2020 Category: Cancer & Oncology Authors: Talvitie EM, Vilhonen H, Kurki S, Karlsson A, Orte K, Almangush A, Mohamed H, Liljeroos L, Singh Y, Leivo I, Laitinen T, Kallajoki M, Taimen P Tags: Neoplasia Source Type: research